Lineage, Inc. Common Stock (LINE)vsRegency Centers Corporation (REG)
LINE
Lineage, Inc. Common Stock
$42.36
+4.23%
REAL ESTATE · Cap: $10.62B
REG
Regency Centers Corporation
$77.12
+0.21%
REAL ESTATE · Cap: $15.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 218% more annual revenue ($5.36B vs $1.69B). REG leads profitability with a 33.0% profit margin vs -2.7%. REG earns a higher WallStSmart Score of 59/100 (C).
LINE
Hold36
out of 100
Grade: F
REG
Buy59
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+44.7%
Fair Value
$138.36
Current Price
$77.12
$61.24 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Reasonable price relative to book value
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Moderate valuation
Expensive relative to growth rate
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : REG
The strongest argument for REG centers on Profit Margin, Operating Margin, Price/Book. Profitability is solid with margins at 33.0% and operating margin at 39.6%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : REG
The primary concerns for REG are P/E Ratio, PEG Ratio, Altman Z-Score.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while REG is a mature play — different risk/reward profiles.
LINE carries more volatility with a beta of 0.91 — expect wider price swings.
REG is growing revenue faster at 8.9% — sustainability is the question.
REG generates stronger free cash flow (48M), providing more financial flexibility.
Bottom Line
REG scores higher overall (59/100 vs 36/100), backed by strong 33.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Regency Centers Corporation
REAL ESTATE · REIT - RETAIL · USA
Regency Centers Corporation is a real estate investment trust based in Jacksonville, Florida and is one of the largest operators of shopping centers with grocery stores as anchor tenants.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?